In a recent study published in Nature Immunology, researchers investigated the direct influence of sodium (Na+) ions on the cytotoxic cluster of differentiation 8 (CD8)-expressing T cells and hence on ...
Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...
T cell-engaging bispecific antibodies (TCEs) are engineered molecules designed to bring cytotoxic T cells into proximity with tumor cells, triggering a targeted, antigen-dependent immune attack.
Detailed price information for Verrica Pharmaceuticals Inc (VRCA-Q) from The Globe and Mail including charting and trades.
Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a ...
Like all hardworking things, the cytotoxic T lymphocytes (CTLs) of the immune system charged with detecting and destroying cancer cells tend to get very tired—so much so, in fact, that they can even ...
Meet the Jekyll and Hyde of the immune system: activated CD8⁺ T cells. On June 24 in Nature Immunology, researchers led by Dorian McGavern at the National Institutes of Health introduce a granzyme ...
Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated a new RNA-based therapeutic strategy that ...
From mutation to medicine: How neoantigen dendritic cell vaccines are reshaping cancer immunotherapy
A new generation of personalized cancer vaccines is taking shape through the use of neoantigen-based dendritic cell (DC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results